Coris Bioconcept Is A Biotechnology Company Based In Belgiumspecializing In Rapid In Vitro Diagnosticsivdfor Infectious Diseasesfounded In 1996 And Headquartered In Gemblouxthe Company Was Acquired By Avacta Group In June 2023Coris Bioconcept Holds Iso 13485 Certification And Ce Marking For Its Productswhich Are Distributed In Over 60 Countries The Company Offers A Range Of Rapid Diagnostic Tests Utilizing Immunochromatographic Technology For Detecting Various Pathogensincluding Bacteriavirusesand Parasitestheir Antimicrobial Resistance Solutionssuch As The Resist Range And The Bl Red Testfocus On Detecting Resistance Mechanisms To Support Infection Controladditionallycoris Bioconcept Provides Molecular Diagnostics Through Rt Lamp Technology And Offers Custom Development Services For Tailored Test Solutionswith A Commitment To User Friendly Diagnosticsthe Company Plays A Significant Role In Addressing Global Antimicrobial Resistance Concerns
United Arab Emirates
